{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:29:53Z","timestamp":1761553793352,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014096","name":"American Society for Metabolic and Bariatric Surgery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","soard.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery for Obesity and Related Diseases"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.soard.2020.01.028","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T11:37:36Z","timestamp":1580902656000},"page":"699-703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management of nonalcoholic fatty liver disease and the role of bariatric surgery: a brief review for surgeons"],"prefix":"10.1016","volume":"16","author":[{"given":"Jay M.","family":"Jorge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Golas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niketa","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Paul","family":"Gonzalvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel M.","family":"Murr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.soard.2020.01.028_bib1","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.soard.2020.01.028_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cld.2017.08.015","article-title":"Nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis in liver transplantation","volume":"22","author":"Carter","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.soard.2020.01.028_bib3","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.soard.2020.01.028_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1381\/096089204772787293","article-title":"The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients","volume":"14","author":"Shalhub","year":"2004","journal-title":"Obes Surg"},{"issue":"3","key":"10.1016\/j.soard.2020.01.028_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11605-014-2678-y","article-title":"Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis","volume":"19","author":"Taitano","year":"2015","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.soard.2020.01.028_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.soard.2020.01.028_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cld.2019.01.001","article-title":"Obstructive sleep apnea and the liver","volume":"23","author":"Parikh","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.soard.2020.01.028_bib8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.21103","article-title":"Similarities and differences in outcomes of cirrhosis due to NASH and hepatitis C","volume":"43","author":"Sanyal","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.soard.2020.01.028_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2013.07.042","article-title":"Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with NAFLD","volume":"60","author":"Cusi","year":"2014","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.soard.2020.01.028_bib10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.soard.2020.01.028_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.21984","article-title":"Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers","volume":"47","author":"Guha","year":"2008","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.soard.2020.01.028_bib12","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.soard.2020.01.028_bib13","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.27362","article-title":"Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study","volume":"60","author":"Loomba","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.soard.2020.01.028_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.soard.2020.01.028_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss via lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.soard.2020.01.028_bib16","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo fornonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.soard.2020.01.028_bib17","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.24544","article-title":"Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial","volume":"54","author":"Zein","year":"2011","journal-title":"Hepatology"},{"issue":"9972","key":"10.1016\/j.soard.2020.01.028_bib18","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.soard.2020.01.028_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jhep.2016.04.021","article-title":"Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"65","author":"Cui","year":"2016","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.soard.2020.01.028_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J Gastroenterol"},{"issue":"12","key":"10.1016\/j.soard.2020.01.028_bib21","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1007\/s11695-015-1691-x","article-title":"Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology","volume":"25","author":"Bower","year":"2015","journal-title":"Obes surg"},{"issue":"3","key":"10.1016\/j.soard.2020.01.028_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.soard.2018.12.002","article-title":"Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis","volume":"15","author":"Fakhry","year":"2019","journal-title":"Surg Obes Relat Dis"},{"issue":"8","key":"10.1016\/j.soard.2020.01.028_bib23","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.soard.2020.01.028_bib24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.soard.2020.01.028_bib25","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11605-009-1032-2","article-title":"Downregulation of adiponectin\/adipoR2 is associated with steatohepatitis in obese mice","volume":"13","author":"Peng","year":"2009","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.soard.2020.01.028_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.soard.2010.05.017","article-title":"Roux-en-Y gastric bypass alters tumor necrosis factor-\u03b1 but not adiponectin signaling in immediate postoperative period in obese rats","volume":"6","author":"Rideout","year":"2010","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"10.1016\/j.soard.2020.01.028_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.soard.2011.07.019","article-title":"Diet-induced obesity associated with steatosis, oxidative stress, and inflammation in liver","volume":"8","author":"Peng","year":"2012","journal-title":"Surg Obes Relat Dis"},{"issue":"2","key":"10.1016\/j.soard.2020.01.028_bib28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jss.2008.11.191","article-title":"Roux-en-Y gastric bypass reduces oxidative stress and downregulates pro-inflammatory genes in livers of obese rats and in Kupffer cells via an AMPK-dependent pathway","volume":"151","author":"Peng","year":"2009","journal-title":"J Surg Res"},{"issue":"2","key":"10.1016\/j.soard.2020.01.028_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11605-009-1102-5","article-title":"Does LKB1 mediate activation of hepatic AMP-protein kinase (AMPK) and sirtuin1 (SIRT1) after Roux-en-Y gastric bypass in obese rats?","volume":"14","author":"Peng","year":"2010","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.soard.2020.01.028_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.soard.2011.06.012","article-title":"Roux-en-Y gastric bypass improves hepatic mitochondrial function in obese rats","volume":"9","author":"Peng","year":"2013","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"10.1016\/j.soard.2020.01.028_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.surg.2017.01.012","article-title":"Roux-en-Y gastric bypass improves glucose homeostasis, reduces oxidative stress and inflammation in livers of obese rats and in Kupffer cells via an AMPK-dependent pathway","volume":"162","author":"Peng","year":"2017","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.soard.2020.01.028_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gutjnl-2014-306748","article-title":"Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis","volume":"64","author":"Verbeek","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.soard.2020.01.028_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41366-019-0420-2","article-title":"Role of ghrelin isoforms in the mitigation of hepatic inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress after bariatric surgery in rats","volume":"44","author":"Ezquerro","year":"2020","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.soard.2020.01.028_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbacli.2015.09.001","article-title":"Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus","volume":"4","author":"Carter","year":"2015","journal-title":"BBA Clin"},{"issue":"3","key":"10.1016\/j.soard.2020.01.028_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2018.11.012","article-title":"Stabilization of lncRNA GAS-5 by a small molecule and its implications in diabetic adipocytes","volume":"26","author":"Shi","year":"2019","journal-title":"Cell Chem Biol"}],"container-title":["Surgery for Obesity and Related Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550728920300496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550728920300496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:13:15Z","timestamp":1761552795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550728920300496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1550728920300496"],"URL":"https:\/\/doi.org\/10.1016\/j.soard.2020.01.028","relation":{},"ISSN":["1550-7289"],"issn-type":[{"type":"print","value":"1550-7289"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of nonalcoholic fatty liver disease and the role of bariatric surgery: a brief review for surgeons","name":"articletitle","label":"Article Title"},{"value":"Surgery for Obesity and Related Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soard.2020.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}